Zobrazeno 1 - 10
of 430
pro vyhledávání: '"Yu An"'
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Cancer
BMC Cancer
Background Nasopharyngeal carcinoma (NPC) is a malignant head and neck tumor, and more than 70% of new cases are in East and Southeast Asia. However, association between NPC and pseudogenes playing important roles in genesis of multiple tumor types i
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background It is reported that appropriately 50% of early breast cancer patients with 1–2 positive sentinel lymph node (SLN) micro-metastases could not benefit from axillary lymph node dissection (ALND) or breast-conserving surgery with whole breas
Autor:
Chen-Hua Yan, Xiao-Dong Mo, Yi-Fei Cheng, Xiao-Su Zhao, Xiao-Jun Huang, Yu Wang, Yu-Hong Chen, Huan Chen, Xiao-Hui Zhang, Wei Han, Ya-Zhen Qin, Juan-Juan Wen, Lan-Ping Xu, Dao-Xing Deng, Feng-Rong Wang, Kai-Yan Liu, Jing-Zhi Wang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background Sequential monitoring of Wilms’ tumor gene 1 (WT1) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) could predict relapse in adult acute myeloid leukemia (AML). However, the prognostic role of WT1 in pediatric AML aft
Autor:
Yu Zhang, Jingyi Chen, Jingzhu Guo, Di Wang, Yuxuan Song, Weidong Yu, Tingru Lin, Jie Sun, Mei Li, Yulan Liu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
BMC Cancer
BMC Cancer
Background Competing endogenous RNA (ceRNA) represents a class of RNAs (e.g., long noncoding RNAs [lncRNAs]) with microRNA (miRNA) binding sites, which can competitively bind miRNA and inhibit its regulation of target genes. Increasing evidence has u
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background MCM3AP-AS1 is a recently characterized lncRNA playing an oncogenic role in several cancers. However, its role in lung cancer remains unknown. Here, we aimed to explore the functions of MCM3AP-AS1 in small cell lung cancer (SCLC) and the po
Autor:
Xin-Yuan Wang, Qing-Wei Zhang, Jialin Meng, Jin-Nan Chen, Fangrong Yan, Xiaofan Lu, Yu-Jie Zhou, Xiaobo Li, Qi-Wen Wang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background Due to negative results in clinical trials of postoperative chemoradiation for gastric cancer, at present, there is a tendency to move chemoradiation therapy forward in gastric and gastroesophageal junction (GEJ) adenocarcinoma. Several ra
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Background Treatment for radioiodine refractory differentiated thyroid carcinoma (RR-DTC) is challenging. The purpose of this study was to assess the efficacy and safety of ultrasound-guided implantation of radioactive 125I-seed in radioiodine refrac
Autor:
Jiawei Yu, Rui Pang, Jinliang Jia, Jiewu Zhang, Wen Bi, Guoqing He, Lili Chen, Zhaoming Ding, Jihua Han, Yanan Sun
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
BMC Cancer
BMC Cancer
Background Terminal differentiation-induced ncRNA (TINCR) plays an essential role in epidermal differentiation and is involved in the development of various cancers. Methods qPCR was used to detect the expression level of TINCR in tissues and cell li
Autor:
Fengwei Tan, Hui Zeng, Jie He, Zheng Wu, Yan Wen, Shugeng Gao, Jiang Li, Yiwen Yu, Yongjie Xu, Ni Li, Yadi Zheng, Zhuoyu Yang, Qi Xue
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
BackgroundPublished findings suggest sex differences in lung cancer risk and a potential role for sex steroid hormones. Our aim was to perform a meta-analysis to investigate the effects of sex steroid hormone exposure specifically on the risk of lung
Autor:
Liwei Wang, Yu Wang, Jiong Hu, Jiujie Cui, Tiebo Mao, Min Liu, Donghui Chen, Yaotian Pan, Jue Liu, Haiyan Zhang, Haiyan Yang, Feng Jiao, Ting Han, Ewelina Biskup
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease that lack of effective therapeutic drugs. K-001 is an oral antitumor drug made from active ingredients of marine microorganisms. The current study aimed to evaluate safety and ant